Abstract. The well-known typical fusion gene BCR/ABL is observed in connection with a complex translocation event in 5-8% of cases of chronic myeloid leukemia (CML). The present study described an exceptional CML case with complex chromosomal aberrations not previously observed. Aberrations included a translocated BCR to the derivative chromosome 2 [der(2)] that also involved a four-chromosome translocation, implying chromosomal regions 1p32 and 2q21, besides 9q34 and 22q11.2, which were characterized by molecular cytogenetics.
Introduction
Chronic myeloid leukemia (CML) is a clonal malignant disorder of pluripotent hematopoetic stem cells progressing from a chronic to an accelerated to a blast phase (1) . The cytogenetic hallmark of CML is the Philadelphia (Ph) chromosome, resulting from t(9;22)(q34;q11), which reflects the rearrangement of the ABL and BCR genes (2) . The Ph chromosome is present in more than 90% of CML cases (3) . In Ph-positive CML, expression of the BCR/ABL chimeric protein p210 with an increased tyrosine kinase activity is essential for multiple signaling pathways to confer the leukemia phenotype (4) .
Complex chromosomal rearrangements involving one or more additional chromosomes have been described in more than 600 CML cases (5) . Using conventional cytogenetic analysis, two variant subgroups have traditionally been identified: complex t(9;22;V) where V represents a third translocation partner chromosome, and simple t(9;V) or t(22;V) (6) . Only a few cases exhibit a chromosomal fragment from the third chromosome translocated to the der(22)t(9;22) producing a 'masked Ph' (7) . In the majority of Ph-variant cases, the segment 22q11-qter shifts to a third chromosome, while a part of the third chromosome is located on 9q34. Deletions on the derivative chromosome 9 occur with a much higher frequency in patients with variant Ph translocations (45%) compared to those with classic Ph (17%) (8) .
We present a CML case with a translocated BCR to der(2), involving four different chromosomal breakpoints characterized by molecular cytogenetics.
Materials and methods
Case report. A 47-year-old female patient was admitted to our Human Genetics Division initially presented with a WBC of 9.66x10 9 /l and splenomegaly. Chromosome analysis using banding cytogenetics revealed a karyotype in accordance with the clinical diagnosis of CML in the chronic phase. She was treated with hydroxyurea (1000 mg/day) for four years and three months. At her initial admission, her hematological parameters were: 85.4% neutrophils, 7.7% lymphocytes and 6.9% immature cells. The platelet count was 372x10 9 /l and the hemoglobin level was 11.8 g/dl. She was initially treated with hydroxyurea for 18 months. Then, 33 months later, following hydroxyurea treatment, her WBC was 130.91x10 9 /l (79.8% neutrophils, 8.5% lymphocytes and 11.7% immature cells). The platelet count was 340x10 9 /l, and the hemoglobin level was 11.9 g/dl.
Banding cytogenetics. Chromosome analyses were performed by the GTG-banding technique according to standard procedures (9) . Twenty metaphases, obtained from the unstimulated bone marrow of the patient, were analyzed. Karyotypes were described according to the International System for Human Cytogenetic Nomenclature (10) .
Fluorescence in situ hybridization (FISH)
. FISH was conducted using commercially available probes. LSI BCR/ABL dualcolor dual-fusion translocation probe (Abbott Molecular/Vysis, USA), whole chromosome painting (WCP) probe for chromosomes 1, 2 and 22 (MetaSystems, Germany) and α satellite probe (CEP) for chromosome 9 (Abbott Molecular/Vysis) were applied according to the standard method (11) . Twenty metaphase spreads were analyzed, using a fluorescence micro-BCR translocation to derivative chromosome 2: A new case of chronic myeloid leukemia with a complex variant translocation and Philadelphia chromosome scope (Axio Imager Z1 mot; Zeiss, Germany) equipped with appropriate filter sets to discriminate between a maximum of five fluorochromes and the counterstain 4'6-diamino-2-phenylindole. Image capturing and processing were carried out using an Isis image analysis system (MetaSystems).
Results
Karyotyping was performed at 3 and 10 months after the initiation of hydroxyurea treatment. The same karyotypic changes were noted. A complex karyotype 46,XX,t(1;2;9;22) was determined in GTG-banding (Fig. 1) , and was further studied by molecular cytogenetics (Figs. 2-4) . Using a commercially available probe specific for BCR/ABL, dual-color FISH showed that the typical Ph chromosome with the BCR/ABL translocation was present. However, BCR was translocated to der(2) (Figs. 2 and 3 ). Another commercially available probe specific for WCP1 + WCP2 + CEP9 confirmed the involvement of chromosome 1 with chromosomes 2 and 9 (Fig. 4) . Thus, FISH was performed using probes for the involved chromosomes according to GTG-banding (Figs. 2-4) . The result obtained was: 46,XX,t(1;2;9;22)(p32;q21;q34;q11.2).
Discussion
The present study identified one additional translocation, 46,XX,t(1;2;9;22)(p32;q21;q34;q11.2), in CML-CP. To the best of our knowledge, this translocation has never been described in the literature (12) .
In 5-8% of CML cases, the fusion gene BCR/ABL is the result of a complex translocation (13) . At present, it appears that variant translocations can affect any chromosome. However, it has been suggested that the distribution of the breakpoints is non-random, with the chromosomal bands  1p36, 3p21, 5q31, 6p21, 9q22, 10q22, 11q13, 12p13, 17p13,  17q21, 17q25, 19q13, 21q22, 22q12 and 22q13 being the most susceptible to breakage (5) . None of the above-mentioned breakpoints were noted in our study. However, the fusion gene is located on chromosome 22.
Two possible mechanisms for variant translocation formation have been suggested. The first is a single-event rearrangement via the simultaneous breakage of several chromosomes followed by mismatched joining (14) . Nacheva et al proposed a classic Ph translocation followed by a further translocation event between chromosomes 9 and 22 plus a third chromosome (15) . The mechanism of the formation of a variant Ph translocation may have prognostic importance in that a two-event mechanism represents clonal evolution, whereas a variant translocation occurring via a single genomic rearrangement may confer a similar prognosis to the classic Ph translocation (16) .
